JEFFREY ABUCAY: Open Payments
NPI 1215186663 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 45 payments from 17 companies in 2025. Trend: 2023 $418 · 2024 $1,148 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 8 | $331 |
| PFIZER INC. | 7 | $156 |
| Biosense Webster, Inc. | 2 | $147 |
| Kestra Medical Technology Services, Inc. | 5 | $146 |
| Boston Scientific Corporation | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| ABIOMED | 3 | $70 |
| Abbott Laboratories | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
Products named: Cleerly Ischemia, CARTO 3, Assure WCD, ELIQUIS, CAMZYOS, VYNDAQEL, WATCHMAN FLX, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across FL — which companies pay providers there.
